Professional Documents
Culture Documents
Drug Study
Drug Study
Drug Study
NAME OF STUDENT: Dela Cruz, Vanessa Mae J. DATE/TIME: September 12, 2022
Patient/family education
Teach patient to report sore
throat, bruising, bleeding,
joint pain; may indicate
blood dyscrasias (rare)
• Advise patient to contact
prescriber if vaginal itching,
loose foul-smelling stools
occur; may indicate
superinfection
• Instruct patient to take all
medication prescribed for
the length of time
prescribed
• Advise patient to notify
prescriber of diarrhea with
blood or pus, which may
indicate
pseudomembranous colitis
Patient/family education
Teach patient to report sore
throat, bruising, bleeding,
joint pain; may indicate
blood dyscrasias (rare)
• Advise patient to contact
prescriber if vaginal itching,
loose foul-smelling stools
occur; may indicate
superinfection
• Instruct patient to take all
medication prescribed for
the length of time
prescribed
• Advise patient to notify
prescriber of diarrhea with
blood or pus, which may
indicate
pseudomembranous colitis
Func. Class: Second-generation upper and lower Hypersensitivity to Rash, diarrhea, increased Assessment
antiinfective cephalosporins respiratory tract, cephalosporins or related transaminases May have • Assess patient for
have same urinary tract, skin antibiotics, seizure serum sickness-like reaction previous sensitivity reaction
Chem. Class: effectiveness as infections, otitis to penicillins or other
Cephalosporin (2nd first-generation and media; bone joint Hypersensitivity to cephalosporins;
Generic generation) increased activity infections cephalosporins or related crosssensitivity between
Name: against gram- antibiotics, seizures B, penicillins and
Cefaclor negative organisms, breastfeeding, Precautions: cephalosporins is common
including Pregnancy children, renal • Assess patient for signs
Brand Haemophilus and symptoms of infection
name: influenzae, including characteristics of
Raniclor Neisseria, wounds, sputum, urine,
Enterobacter, and stool, WBC .10,000/mm3 ,
Drug several anaerobic earache, fever; obtain
Order: 2nd organisms. baseline information and
generation during treatment
Cephalosporins • Obtain C&S before
inhibit cell wall beginning product therapy
synthesis or to identify if correct
activate enzymes treatment has been
that disrupt the cell initiated 187 C Canada only
wall, causing cell Adverse effects: italics =
lysis and cell death. common; bold = life-
May be threatening cephalosporins
bacteriostatic or —3rd/4th generation
bactericidal. Most • Assess for anaphylaxis:
effective against rash, urticaria, pruritus,
rapidly dividing dyspnea, chills, fever, joint
cells. pain; angio edema may
occur a few days after
therapy begins;
epinephrine and
resuscitation equipment
should be available for
anaphylactic reaction
• Identify urine output; if
decreasing, notify
prescriber (may indicate
nephrotoxicity); also check
for increased BUN,
creatinine
Patient/family education
• Teach patient to report
sore throat, bruising,
bleeding, joint pain; may
indicate blood dyscrasias
(rare); symptoms of
hypersensitivity
• Advise patient to contact
prescriber if vaginal itching,
loose foul-smelling stools,
furry tongue occur; may
indicate superinfection
• Instruct patient to take all
medication prescribed for
the length of time ordered;
to use yogurt or buttermilk
to maintain intestinal flora,
decrease diarrhea